Substantial Reduction in Adjuvant Chemotherapy With the Use of the 21-Gene Test to Manage Early Breast Cancer in a Public Hospital in Brazil

We evaluated the impact of 21-gene test results on treatment decisions for patients with early-stage breast cancer treated under the public health care system in Brazil, Sistema Único de Saúde. METHODS: Eligible patients treated at Hospital Pérola Byington and Santa Casa de Misericórdia de São Paulo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattar, André, Fonseca, Guilherme R., Romão, Murilo B. A., Shida, Jorge Y., de Oliveira, Vilmar M., Bastos, Maria C. S., Bagnoli, Fabio, Rinaldi, Jose F., Stiepcich, Monica M. Á., da Silva, Maria A. L. G., Jakubowski, Debbie M., Chao, Calvin, Oliveira, Sergio C., Gebrim, Luiz H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457870/
https://www.ncbi.nlm.nih.gov/pubmed/34181482
http://dx.doi.org/10.1200/GO.20.00609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457870/
https://www.ncbi.nlm.nih.gov/pubmed/34181482
http://dx.doi.org/10.1200/GO.20.00609

Ejemplares similares